Skip to main content
[Preprint]. 2024 Sep 11:2024.09.10.24313079. [Version 1] doi: 10.1101/2024.09.10.24313079

Table 1:

Participant characteristics from the SPIROMICS and COPDGene cohorts at baseline.

SPIROMICS COPDGene P Value

(n = 1458) (n = 458)

Age, years 62.86 (9.13) 63.30 (8.52) 0.6
Race < 0.001
 White 1,138 (78%) 454 (99%)
 Non-White 320 (22%) 4 (0.9%)
Sex 0.008
 Male 788 (54%) 215 (47%)
 Female 670 (46%) 243 (53%)
BMI, kg / m2 28.08 (5.18) 29.93 (6.16) < 0.001
Smoking status < 0.001
 Former or never smokers 870 (60%) 328 (72%)
 Current smokers 588 (40%) 130 (28%)
Smoking pack years 46.62 (28.11) 39.42 (23.77) < 0.001
Postbronchodilator FEV1, L 2.29 (0.87) 2.50 (0.75) < 0.001
FEV1 / FVC ratio 0.64 (0.15) 0.71 (0.12) < 0.001
GOLD stage < 0.001
 0 579 (40%) 240 (52%)
 1 165 (11%) 44 (9.6%)
 2 468 (32%) 78 (17%)
 3 164 (11%) 25 (5.5%)
 4 33 (2.3%) 1 (0.2%)
 Never smokers 49 (3.4%) 18 (3.9%)
 PRISm NA 52 (11%)
Total SGRQ score 30.18 (20.48) 12.48 (15.26) < 0.001
6MWD, ft 1,342.01 (361.23) 1,599.13 (336.83) < 0.001
mMRC dyspnea scale 0.95 (0.95) 0.64 (1.05) < 0.001
fSADPRM, % 13.35 (12.21) 10.13 (9.46) < 0.001
fSADTLC, % 12.98 (13.25) 9.55 (10.99) 0.002
CT emphysema (LAA < −950 HU), % 6.59 (9.07) 3.84 (5.88) < 0.001

Data reported as mean (SD) or n (%). SPIROMICS = SubPopulations and InteRmediate Outcome Measure In COPD; COPDGene = Genetic Epidemiology of CoPD; BMI = body-mass index (kg / m2); FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; GOLD = Global Initiative for Obstructive Lung Disease; PRISm = preserved ratio impaired spirometry; SGRQ = St. George’s Respiratory Questionnaire; 6MWD = six minute walk distance (ft); mMRC = modified Medical Research Council; fSAD = functional small airways disease; TLC = total lung capacity; PRM = parametric response mapping; CT = computed tomography; LAA = low-attenuation areas (%). P values were generated using Wilcoxon’s rank sum test or Pearson’s Chi-squared test.